Range VC — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Cascade Biocatalysts develops engineered biocatalysts designed to be more cost efficient, reusable, and longer-lasting with a wider operating window and higher output.
BiotechCleantechDeep TechNew MaterialsDenver, US
James Weltz(Executive Officer, Director, Promoter)inAlex Rosay(Founder)in
BoardJared Campbell(Director)
Co-investorsAmplify.LACool Climate CollectiveSpacecadet VenturesBoost VCTen VC
Cime Therapeutics is developing a chemistry-first drug discovery platform that combines automation, AI/ML, and synthetic chemistry to make molecules faster and more cost-effectively.
AI & Machine LearningBiotechDeep TechDenver, US
James Brewster(Chief Executive Officer)inJames Thomas Brewster II(Executive Officer, Director)
BoardChris Erickson(Director)in
Co-investorsDYDX CapitalService Provider Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.